Despite recommendations from the International Ki-67 in Breast Cancer Working Group the inter-observer variability of routine Ki-67 assessment in breast cancer remains poor to moderate especially in the G2 breast cancer group (Kappa: 0.2–0.4) [3, 8–12]. Here, MKI67 is linked to breast carcinoma.